Twitter | Search | |
Herantis Pharma
New therapies for a better life.
169
Tweets
26
Following
208
Followers
Tweets
Herantis Pharma 17m
We are hiring! Looking for In Vivo Pharmacologist to support our development of disease-modifying drug for and other neurodegenerative diseases.
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula May 20
in full swing in Barcelona! Busy with 1:1 meetings, also time for some plenary sessions.
Reply Retweet Like
Herantis Pharma May 7
First bi-monthly Herantis newsletter published!
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Apr 24
Nice interview on and our plans in , and more. Thanks !
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Apr 22
Lymfactin development continues as planned! 12-month follow-up reported from Phase 1 Trial in Breast Cancer-Associated
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Apr 15
premier in ! Exec interview explains our development in and .
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Mar 28
Full house at listening to 's Henri Huttunen on CDNF clinical study in !
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Mar 24
BioStock's Sunday interview: Why global healthcare fund Medica invested in ! (In Swedish but google translates well)
Reply Retweet Like
Herantis Pharma Mar 18
Thank you for all your support & great collaboration toward finding a cure for lymphedema!
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Mar 18
Small cap event including COO Antti Vuolanto!
Reply Retweet Like
Herantis Pharma Mar 15
Mitä on lymfaturvotus eli lymfedeema? Voiko siihen saada apua? Tutustu uuteen Lymfactin-sivustoomme!
Reply Retweet Like
Herantis Pharma Mar 15
Important milestone in our drug development for patients with and !
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Mar 6
Today is World Lymphedema Day. Get involved! Don't know what lymphedema is? Spend a minute to learn. It's now estimated to affect 250 million people and there's no cure.
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Feb 14
Herantis Pharma is planning directed share issue and prepares for secondary listing in First North Stockholm:
Reply Retweet Like
Herantis Pharma retweeted
Kanzan Media Feb 11
Welcome - Herantis Pharma Oyj. The full interview with the CEO of the company Pekka Simula has just been published. For more information on this company based in Espoo, Finland please visit
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Oct 25
What's new and our clinical development? See video presentation from from
Reply Retweet Like
Herantis Pharma Sep 28
We are hiring! Project Manager for clinical studies, anyone?
Reply Retweet Like
Herantis Pharma retweeted
Suomen Bioteollisuus Sep 25
Are you interested in mentoring or looking for a mentor? Sign up for the LS-Mentors -web service for Finnish Life Science entrepreneurs, startups and researchers! Provided by and
Reply Retweet Like
Herantis Pharma Sep 20
Initiation report on Herantis includes good analysis on need for better treatments for and . Read
Reply Retweet Like
Herantis Pharma retweeted
Pekka Simula Sep 11
Great discussions in Stockholm ! Should our industry develop drugs similar to those already known, or boldly innovate toward breakthru that really matters for patients? I vote for the latter.
Reply Retweet Like